Humacyte plans to file a supplemental Biologic License Application (BLA) with the Food and Drug Administration (FDA) during the second half of ...
Selecting the most effective hemodialysis access method is arguably the most crucial decision in managing end-stage renal disease. Two of the most widely used surgical options are the Cimino ...
The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...
Briefly, this is how the AV fistula operation is performed: After ad-ministering local anesthesia, the surgeon makes a small incision over the patient’s radial pulse, mobilizes the radial artery, and ...
An AV fistula may fail for various reasons, including low or poor blood flow, failure to mature, excessive pain, a sclerotic vein, and a thrombotic vein. Failure can be disheartening to a patient who ...
WASHINGTON--(BUSINESS WIRE)--The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week’s Controversies in Dialysis Access (CiDA) ...
Please provide your email address to receive an email when new articles are posted on . Published findings report that, for vascular access in hemodialysis, the creation of an arteriovenous fistula ...
The Progressive Healthworkers Forum, a coalition of multidisciplinary healthcare professionals, is offering free AV fistula surgeries to chronic kidney disease patients across Delta State to mark ...
The endoscopic device manufactured by Maquet was originally developed for harvesting of the saphenous vein and radial artery as conduits for coronary artery bypass graft surgery. These vessels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results